Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Zosano Pharma Corporation
ZSANQ
Healthcare
Biotechnology
Zosano Pharma Corp is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Zosano Pharma Corp is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K...
, Annual Reports) filed by Zosano Pharma Corp. Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications. The company only operating segment being developing human pharmaceutical products. All the business activities of the firm is functioned through the market of the United States. Its product includes Qtrypta (M207) which is a formulation of zolmitriptan delivered utilizing an Adhesive Dermally-Applied Microarray technology.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (EXPM:ZSANQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
RockyIV
X
View Profile
View Bullboard History
Comment by
RockyIV
on May 16, 2022 4:28pm
RE:Must Have
(0)
•••
RockyIV
X
View Profile
View Bullboard History
Post by
RockyIV
on May 16, 2022 4:26pm
Must Have
Every board can use a can.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 17, 2021 9:28am
ZSAN .....up on volume and early a.m NR
Not a small float On watch just the same
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Nov 17, 2021 9:03am
ZSAN:SUCCESSFUL FORMULA OF COVID VACC MICRONEEDLE PATCH SYS.
Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System Wed, November 17, 2021, 8:00 AM·4 min read FREMONT, Calif., Nov. 17
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Feb 09, 2021 10:03am
Avg volume for zsan is 7 mlns/ tdy's vol so far is 56 mlns
anyone is aware of any possible pending news? thx
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Jan 05, 2021 8:29am
ZSAN TO PRESENT AT H.C. WAINWRIGHT VIRTUAL BIOCONNECT CONF.
Zosano Pharma to Present at the H.C. Wainwright Virtual BioConnect Conference January 04, 2021 08:30 ET | Source: Zosano Pharma Corporation FREMONT, Calif., Jan. 04, 2021 (GLOBE
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Jan 05, 2021 8:27am
ZSAN REQUESTED MEETING + FDA TO RESUBMIT APPS FOR QRYPTA &
Zosano Pharma Requests Type A Meeting with the FDA to Review Resubmission Plans for Qtrypta™ New Drug Application Zosano Pharma Corporation Mon, January 4, 2021, 4:05 PM EST·3 min
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Oct 22, 2020 9:23am
ZSAN CAN'T BE WRITTEN OFF (ARTICLE) !
Zosano Pharma Corporation (ZSAN) can’t be written off after posting last 3-months Average volume of 6.36M BySarah Baker - October 21, 2020 Let’s start up with the current stock price of
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Oct 13, 2020 8:35am
ZSAN OCT 25TH FDA APPROVAL DATE DELAYED BY FDA!
FDA trips up Zosano Pharma's migraine patch 3 weeks before approval date Steven Lo is CEO of Zosano Pharma Corp. COURTESY OF ZOSANO PHARMA By Ron Leuty – Staff Reporter,
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on May 12, 2020 2:09pm
zsan APPOINTS CHRISTINE MATHEWS AS PERMANENT CFO
May 01, 2020 Zosano Pharma Announces the Appointment of Christine Matthews as Chief Financial Officer FREMONT, Calif., May 01, 2020 (GLOBE NEWSWIRE) - - Zosano
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on May 12, 2020 2:06pm
ZSAN gets a date with the FDA FOR POSSIBLE APPROVAL OF DRUG
this could explain what casuing the surge ofthe zsan stock this month.. Nearly $300M, six CEOs and dead-ends later, East Bay drugmaker gets date with FDA for migraine treatment Steven Lo is
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Dec 23, 2019 8:33am
zsan submitted FDA APP FOR QRYPTA,EXPECTED ANSWER MAR 2020
Zosano Announces FDA Submission of New Drug Application for Qtrypta December 23, 2019 08:00 ET | Source: Zosano Pharma Corporation FREMONT, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE)
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Nov 27, 2019 10:23pm
zsan 2mlns shares offering at 1.45 per share
Zosano prices registered direct offering Nov. 27, 2019 11:05 AM ET |About: Zosano Pharma Corporation (ZSAN)|By: Niloofer Shaikh, SA News Editor
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Nov 07, 2019 9:28am
ZSAN EARNINGS NOV 14 FOLLOWED BY CONF CALL AT 4:30 PM
Zosano Pharma to Host Conference Call on Third Quarter 2019 Financial Results and Provide Operational Update November 07, 2019 09:00 ET | Source: Zosano Pharma Corporation
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Oct 25, 2019 9:36am
ZSAN LAUNCHES PHASE 2/3 STUDY FOR CLUSTER HEADACHE
Zosano launches Phase 2/3 study of zolmitriptan for cluster headache Oct. 24, 2019 10:33 AM ET|About: Zosano Pharma Corporation (ZSAN)|By: Douglas W. House, SA News Editor Enrollment
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >